請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21015
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 邱繼輝(Kay-Hooi Khoo) | |
dc.contributor.author | Yu-Dai Kuo | en |
dc.contributor.author | 郭玉岱 | zh_TW |
dc.date.accessioned | 2021-06-08T03:15:43Z | - |
dc.date.copyright | 2017-02-22 | |
dc.date.issued | 2017 | |
dc.date.submitted | 2017-02-06 | |
dc.identifier.citation | Abdi, R., Fiorina, P., Adra, C. N., Atkinson, M., & Sayegh, M. H. (2008). Immunomodulation by mesenchymal stem cells: a potential therapeutic strategy for type 1 diabetes. Diabetes, 57(7), 1759-1767.
Adewumi, O., Aflatoonian, B., Ahrlund-Richter, L., Amit, M., Andrews, P. W., Beighton, G., et al. (2007). Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol, 25(7), 803-816. Altamirano, J., & Bataller, R. (2011). Alcoholic liver disease: pathogenesis and new targets for therapy. Nat Rev Gastroenterol Hepatol, 8(9), 491-501. Alviano, F., Fossati, V., Marchionni, C., Arpinati, M., Bonsi, L., Franchina, M., et al. (2007). Term Amniotic membrane is a high throughput source for multipotent Mesenchymal Stem Cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol, 7, 11. Ame-Thomas, P., Maby-El Hajjami, H., Monvoisin, C., Jean, R., Monnier, D., Caulet-Maugendre, S., et al. (2007). Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood, 109(2), 693-702. Aoki, K., Perlman, M., Lim, J. M., Cantu, R., Wells, L., & Tiemeyer, M. (2007). Dynamic developmental elaboration of N-linked glycan complexity in the Drosophila melanogaster embryo. J Biol Chem, 282(12), 9127-9142. Ashline, D., Singh, S., Hanneman, A., & Reinhold, V. (2005). Congruent strategies for carbohydrate sequencing. 1. Mining structural details by MSn. Anal Chem, 77(19), 6250-6262. Astarita, J. L., Acton, S. E., & Turley, S. J. (2012). Podoplanin: emerging functions in development, the immune system, and cancer. Front Immunol, 3, 283. Badcock, G., Pigott, C., Goepel, J., & Andrews, P. W. (1999). The human embryonal carcinoma marker antigen TRA-1-60 is a sialylated keratan sulfate proteoglycan. Cancer Res, 59(18), 4715-4719. Baenziger, J. U., Kumar, S., Brodbeck, R. M., Smith, P. L., & Beranek, M. C. (1992). Circulatory half-life but not interaction with the lutropin/chorionic gonadotropin receptor is modulated by sulfation of bovine lutropin oligosaccharides. Proc Natl Acad Sci U S A, 89(1), 334-338. Barilani, M., Lavazza, C., Vigano, M., Montemurro, T., Boldrin, V., Parazzi, V., et al. (2015). Dissection of the cord blood stromal component reveals predictive parameters for culture outcome. Stem Cells Dev, 24(1), 104-114. Bernardo, M. E., & Fibbe, W. E. (2012). Safety and efficacy of mesenchymal stromal cell therapy in autoimmune disorders. Ann N Y Acad Sci, 1266, 107-117. Beyer Nardi, N., & da Silva Meirelles, L. (2006). Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb Exp Pharmacol(174), 249-282. Bianco, P., & Gehron Robey, P. (2000). Marrow stromal stem cells. J Clin Invest, 105(12), 1663-1668. Bianco, P., Riminucci, M., Gronthos, S., & Robey, P. G. (2001). Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells, 19(3), 180-192. Björndal, H., Hellerqvist, C.G., Lindberg, B. and Svensson, S. (1970) Gas-Liquid Chromatography and Mass Spectrometry in Methylation Analysis of Polysaccharides. Angewandte Chemie International Edition in English, (9), 610-619. Bochner, B. S., Alvarez, R. A., Mehta, P., Bovin, N. V., Blixt, O., White, J. R., et al. (2005). Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem, 280(6), 4307-4312. Bonfanti, L. (2006). PSA-NCAM in mammalian structural plasticity and neurogenesis. Prog Neurobiol, 80(3), 129-164. Boregowda, S. V., & Phinney, D. G. (2012). Therapeutic applications of mesenchymal stem cells: current outlook. BioDrugs, 26(4), 201-208. Brimble, S. N., Sherrer, E. S., Uhl, E. W., Wang, E., Kelly, S., Merrill, A. H., Jr., et al. (2007). The cell surface glycosphingolipids SSEA-3 and SSEA-4 are not essential for human ESC pluripotency. Stem Cells, 25(1), 54-62. Brunt, K. R., Weisel, R. D., & Li, R. K. (2012). Stem cells and regenerative medicine - future perspectives. Can J Physiol Pharmacol, 90(3), 327-335. Butcher, E. C., & Picker, L. J. (1996). Lymphocyte homing and homeostasis. Science, 272(5258), 60-66. Carlsson, S., Oberg, C. T., Carlsson, M. C., Sundin, A., Nilsson, U. J., Smith, D., et al. (2007). Affinity of galectin-8 and its carbohydrate recognition domains for ligands in solution and at the cell surface. Glycobiology, 17(6), 663-676. Chai, W., Piskarev, V., & Lawson, A. M. (2001). Negative-ion electrospray mass spectrometry of neutral underivatized oligosaccharides. Anal Chem, 73(3), 651-657. Chai, W., Piskarev, V., & Lawson, A. M. (2002). Branching pattern and sequence analysis of underivatized oligosaccharides by combined MS/MS of singly and doubly charged molecular ions in negative-ion electrospray mass spectrometry. J Am Soc Mass Spectrom, 13(6), 670-679. Cheng, C. W., Chou, C. C., Hsieh, H. W., Tu, Z., Lin, C. H., Nycholat, C., et al. (2015). Efficient Mapping of Sulfated Glycotopes by Negative Ion Mode nanoLC-MS/MS-Based Sulfoglycomic Analysis of Permethylated Glycans. Anal Chem, 87(12), 6380-6388. Cheng, P. F., Snovida, S., Ho, M. Y., Cheng, C. W., Wu, A. M., & Khoo, K. H. (2013). Increasing the depth of mass spectrometry-based glycomic coverage by additional dimensions of sulfoglycomics and target analysis of permethylated glycans. Anal Bioanal Chem, 405(21), 6683-6695. Ciucanu, I., & Kerek, F. (1984). A simple and rapid method for the permethylation of carbohydrates. Carbohydrate Research, 131(2), 209-217. Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011). Human fatty liver disease: old questions and new insights. Science, 332(6037), 1519-1523. Cook, D., & Genever, P. (2013). Regulation of mesenchymal stem cell differentiation. Adv Exp Med Biol, 786, 213-229. Cummings, R. D. (2009). The repertoire of glycan determinants in the human glycome. Mol Biosyst, 5(10), 1087-1104. Deans, R. J., & Moseley, A. B. (2000). Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol, 28(8), 875-884. Dell, A. (1987) F.A.B.-mass spectrometry of carbohydrates. Adv Carbohydr Chem Bioche, (45), 19-72. Dell, A., Morris, H.R., Egge, H., von Nicolai, H. and Strecker, G. (1983) Fast-atom-bombardment mass-spectrometry for carbohydrate-structure determination. Carbohydrate Research, (115), 41-52. Dell, A., & Morris, H. R. (2001). Glycoprotein structure determination by mass spectrometry. Science, 291(5512), 2351-2356. Dell, A., Reason, A. J., Khoo, K. H., Panico, M., McDowell, R. A., & Morris, H. R. (1994). Mass spectrometry of carbohydrate-containing biopolymers. Methods Enzymol, 230, 108-132. Dennis, J. W., Granovsky, M., & Warren, C. E. (1999). Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta, 1473(1), 21-34. Diamandis, E. P. (2004). Mass spectrometry as a diagnostic and a cancer biomarker discovery tool: opportunities and potential limitations. Mol Cell Proteomics, 3(4), 367-378. Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I., Marini, F., Krause, D., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8(4), 315-317. Draper, J. S., Pigott, C., Thomson, J. A., & Andrews, P. W. (2002). Surface antigens of human embryonic stem cells: changes upon differentiation in culture. J Anat, 200(Pt 3), 249-258. Dykstra, B., Lee, J., Mortensen, L. J., Yu, H., Wu, Z. L., Lin, C. P., et al. (2016). Glycoengineering of E-Selectin Ligands by Intracellular versus Extracellular Fucosylation Differentially Affects Osteotropism of Human Mesenchymal Stem Cells. Stem Cells, 34(10), 2501-2511. Egge, H. and Peter-Katalinic, J. (1987) Fast atom bombardment mass spectrometry for structural elucidation of glycoconjugates. Mass Spectrom Rev, (6), 31-393. Falany, C. N. (1997). Enzymology of human cytosolic sulfotransferases. Faseb j, 11(4), 206-216. Fan, Y. Y., Yu, S. Y., Ito, H., Kameyama, A., Sato, T., Lin, C. H., et al. (2008). Identification of further elongation and branching of dimeric type 1 chain on lactosylceramides from colonic adenocarcinoma by tandem mass spectrometry sequencing analyses. J Biol Chem, 283(24), 16455-16468. Farr, A., Nelson, A., & Hosier, S. (1992). Characterization of an antigenic determinant preferentially expressed by type I epithelial cells in the murine thymus. J Histochem Cytochem, 40(5), 651-664. Fiete, D., Srivastava, V., Hindsgaul, O., & Baenziger, J. U. (1991). A hepatic reticuloendothelial cell receptor specific for SO4-4GalNAc beta 1,4GlcNAc beta 1,2Man alpha that mediates rapid clearance of lutropin. Cell, 67(6), 1103-1110. Fletcher, A. L., Acton, S. E., & Knoblich, K. (2015). Lymph node fibroblastic reticular cells in health and disease. Nat Rev Immunol, 15(6), 350-361. Floyd, H., Ni, J., Cornish, A. L., Zeng, Z., Liu, D., Carter, K. C., et al. (2000). Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J Biol Chem, 275(2), 861-866. Fu, Y., Xu, S., Pan, C., Ye, M., Zou, H., & Guo, B. (2006). A matrix of 3,4-diaminobenzophenone for the analysis of oligonucleotides by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Nucleic Acids Res, 34(13), e94. Fukuda, M., Hiraoka, N., Akama, T. O., & Fukuda, M. N. (2001). Carbohydrate-modifying sulfotransferases: structure, function, and pathophysiology. J Biol Chem, 276(51), 47747-47750. Futterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H., & Pfeffer, K. (1998). The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity, 9(1), 59-70. Gagneux, P., & Varki, A. (1999). Evolutionary considerations in relating oligosaccharide diversity to biological function. Glycobiology, 9(8), 747-755. Geyer, R. and Geyer, H. (1994) Saccharide linkage analysis using methylation and other techniques. Methods Enzymo, (230), 86-108. Giordano, A., Galderisi, U., & Marino, I. R. (2007). From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J Cell Physiol, 211(1), 27-35. Gommerman, J. L., & Browning, J. L. (2003). Lymphotoxin/light, lymphoid microenvironments and autoimmune disease. Nat Rev Immunol, 3(8), 642-655. Gooi, H. C., Feizi, T., Kapadia, A., Knowles, B. B., Solter, D., & Evans, M. J. (1981). Stage-specific embryonic antigen involves alpha 1 goes to 3 fucosylated type 2 blood group chains. Nature, 292(5819), 156-158. Griffin, M. D., Elliman, S. J., Cahill, E., English, K., Ceredig, R., & Ritter, T. (2013). Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots? Stem Cells, 31(10), 2033-2041. Grunwell, J. R., & Bertozzi, C. R. (2002). Carbohydrate sulfotransferases of the GalNAc/Gal/GlcNAc6ST family. Biochemistry, 41(44), 13117-13126. Gupta, G., Surolia, A., & Sampathkumar, S. G. (2010). Lectin microarrays for glycomic analysis. Omics, 14(4), 419-436. Hakomori, S. (1964). A RAPID PERMETHYLATION OF GLYCOLIPID, AND POLYSACCHARIDE CATALYZED BY METHYLSULFINYL CARBANION IN DIMETHYL SULFOXIDE. J Biochem, 55, 205-208. Hamouda, H., Ullah, M., Berger, M., Sittinger, M., Tauber, R., Ringe, J., et al. (2013). N-glycosylation profile of undifferentiated and adipogenically differentiated human bone marrow mesenchymal stem cells: towards a next generation of stem cell markers. Stem Cells Dev, 22(23), 3100-3113. Harvey, D. J. (2000a). Collision-induced fragmentation of underivatized N-linked carbohydrates ionized by electrospray. J Mass Spectrom, 35(10), 1178-1190. Harvey, D. J. (2000b). Electrospray mass spectrometry and fragmentation of N-linked carbohydrates derivatized at the reducing terminus. J Am Soc Mass Spectrom, 11(10), 900-915. Harvey, D. J. (2000c). N-(2-diethylamino)ethyl-4-aminobenzamide derivative for high sensitivity mass spectrometric detection and structure determination of N-linked carbohydrates. Rapid Commun Mass Spectrom, 14(10), 862-871. Harvey, D. J. (2005a). Fragmentation of negative ions from carbohydrates: part 1. Use of nitrate and other anionic adducts for the production of negative ion electrospray spectra from N-linked carbohydrates. J Am Soc Mass Spectrom, 16(5), 622-630. Harvey, D. J. (2005b). Fragmentation of negative ions from carbohydrates: part 2. Fragmentation of high-mannose N-linked glycans. J Am Soc Mass Spectrom, 16(5), 631-646. Harvey, D. J. (2005c). Fragmentation of negative ions from carbohydrates: part 3. Fragmentation of hybrid and complex N-linked glycans. J Am Soc Mass Spectrom, 16(5), 647-659. Harvey, D. J., Bateman, R. H., Bordoli, R. S., & Tyldesley, R. (2000). Ionisation and fragmentation of complex glycans with a quadrupole time-of-flight mass spectrometer fitted with a matrix-assisted laser desorption/ionisation ion source. Rapid Commun Mass Spectrom, 14(22), 2135-2142. Hasehira, K., Hirabayashi, J., & Tateno, H. (2016). Structural and quantitative evidence of alpha2-6-sialylated N-glycans as markers of the differentiation potential of human mesenchymal stem cells. Glycoconj J. Hebert, A. S., Richards, A. L., Bailey, D. J., Ulbrich, A., Coughlin, E. E., Westphall, M. S., et al. (2014). The one hour yeast proteome. Mol Cell Proteomics, 13(1), 339-347. Heiskanen, A., Hirvonen, T., Salo, H., Impola, U., Olonen, A., Laitinen, A., et al. (2009). Glycomics of bone marrow-derived mesenchymal stem cells can be used to evaluate their cellular differentiation stage. Glycoconj J, 26(3), 367-384. Hemmerich, S., & Rosen, S. D. (2000). Carbohydrate sulfotransferases in lymphocyte homing. Glycobiology, 10(9), 849-856. Hiraoka, N., Kawashima, H., Petryniak, B., Nakayama, J., Mitoma, J., Marth, J. D., et al. (2004). Core 2 branching beta1,6-N-acetylglucosaminyltransferase and high endothelial venule-restricted sulfotransferase collaboratively control lymphocyte homing. J Biol Chem, 279(4), 3058-3067. Hirvonen, T., Suila, H., Kotovuori, A., Ritamo, I., Heiskanen, A., Sistonen, P., et al. (2012). The i blood group antigen as a marker for umbilical cord blood-derived mesenchymal stem cells. Stem Cells Dev, 21(3), 455-464. Holt, G. D., & Hart, G. W. (1986). The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem, 261(17), 8049-8057. Hooper, L. V., Manzella, S. M., & Baenziger, J. U. (1996). From legumes to leukocytes: biological roles for sulfated carbohydrates. Faseb j, 10(10), 1137-1146. Huang, I. H., Hsiao, C. T., Wu, J. C., Shen, R. F., Liu, C. Y., Wang, Y. K., et al. (2014). GEF-H1 controls focal adhesion signaling that regulates mesenchymal stem cell lineage commitment. J Cell Sci, 127(Pt 19), 4186-4200. Huang, L., & Burd, A. (2012). An update review of stem cell applications in burns and wound care. Indian J Plast Surg, 45(2), 229-236. Jones, K. A., Kim, P. D., Patel, B. B., Kelsen, S. G., Braverman, A., Swinton, D. J., et al. (2013). Immunodepletion plasma proteomics by tripleTOF 5600 and Orbitrap elite/LTQ-Orbitrap Velos/Q exactive mass spectrometers. J Proteome Res, 12(10), 4351-4365. Kaldjian, E. P., Gretz, J. E., Anderson, A. O., Shi, Y., & Shaw, S. (2001). Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int Immunol, 13(10), 1243-1253. Kameyama, A., Kikuchi, N., Nakaya, S., Ito, H., Sato, T., Shikanai, T., et al. (2005). A strategy for identification of oligosaccharide structures using observational multistage mass spectral library. Anal Chem, 77(15), 4719-4725. Kaneko, M., Kato, Y., Kunita, A., Fujita, N., Tsuruo, T., & Osawa, M. (2004). Functional sialylated O-glycan to platelet aggregation on Aggrus (T1alpha/Podoplanin) molecules expressed in Chinese hamster ovary cells. J Biol Chem, 279(37), 38838-38843. Kaneko, M. K., Kato, Y., Kameyama, A., Ito, H., Kuno, A., Hirabayashi, J., et al. (2007). Functional glycosylation of human podoplanin: glycan structure of platelet aggregation-inducing factor. FEBS Lett, 581(2), 331-336. Kang, P., Mechref, Y., Klouckova, I., & Novotny, M. V. (2005). Solid-phase permethylation of glycans for mass spectrometric analysis. Rapid Commun Mass Spectrom, 19(23), 3421-3428. Katakai, T., Hara, T., Sugai, M., Gonda, H., & Shimizu, A. (2004). Lymph node fibroblastic reticular cells construct the stromal reticulum via contact with lymphocytes. J Exp Med, 200(6), 783-795. Kawashima, H. (2006). Roles of sulfated glycans in lymphocyte homing. Biol Pharm Bull, 29(12), 2343-2349. Kawashima, H., & Fukuda, M. (2012). Sulfated glycans control lymphocyte homing. Ann N Y Acad Sci, 1253, 112-121. Kawashima, H., Petryniak, B., Hiraoka, N., Mitoma, J., Huckaby, V., Nakayama, J., et al. (2005). N-acetylglucosamine-6-O-sulfotransferases 1 and 2 cooperatively control lymphocyte homing through L-selectin ligand biosynthesis in high endothelial venules. Nat Immunol, 6(11), 1096-1104. Kern, S., Eichler, H., Stoeve, J., Kluter, H., & Bieback, K. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24(5), 1294-1301. Keyser, K. A., Beagles, K. E., & Kiem, H. P. (2007). Comparison of mesenchymal stem cells from different tissues to suppress T-cell activation. Cell Transplant, 16(5), 555-562. Khoo, K.-H., & Yu, S.-Y. (2010). Mass Spectrometric Analysis of Sulfated N- and O-Glycans. 478, 3-26. Kikly, K. K., Bochner, B. S., Freeman, S. D., Tan, K. B., Gallagher, K. T., D'Alessio K, J., et al. (2000). Identification of SAF-2, a novel siglec expressed on eosinophils, mast cells, and basophils. J Allergy Clin Immunol, 105(6 Pt 1), 1093-1100. Kimura, N., Ohmori, K., Miyazaki, K., Izawa, M., Matsuzaki, Y., Yasuda, Y., et al. (2007). Human B-lymphocytes express alpha2-6-sialylated 6-sulfo-N-acetyllactosamine serving as a preferred ligand for CD22/Siglec-2. J Biol Chem, 282(44), 32200-32207. Kitagawa, H., Fujita, M., Ito, N., & Sugahara, K. (2000). Molecular cloning and expression of a novel chondroitin 6-O-sulfotransferase. J Biol Chem, 275(28), 21075-21080. Kiwamoto, T., Katoh, T., Evans, C. M., Janssen, W. J., Brummet, M. E., Hudson, S. A., et al. (2015). Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis. J Allergy Clin Immunol, 135(5), 1329-1340.e1321-1329. Kiwamoto, T., Kawasaki, N., Paulson, J. C., & Bochner, B. S. (2012). Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions. Pharmacol Ther, 135(3), 327-336. Kolarich, D., Lepenies, B., & Seeberger, P. H. (2012). Glycomics, glycoproteomics and the immune system. Curr Opin Chem Biol, 16(1-2), 214-220. Lanctot, P. M., Gage, F. H., & Varki, A. P. (2007). The glycans of stem cells. Curr Opin Chem Biol, 11(4), 373-380. Lapadula, A. J., Hatcher, P. J., Hanneman, A. J., Ashline, D. J., Zhang, H., & Reinhold, V. N. (2005). Congruent strategies for carbohydrate sequencing. 3. OSCAR: an algorithm for assigning oligosaccharide topology from MSn data. Anal Chem, 77(19), 6271-6279. Lee, J. K., Bistrup, A., van Zante, A., & Rosen, S. D. (2003). Activities and expression pattern of the carbohydrate sulfotransferase GlcNAc6ST-3 (I-GlcNAc6ST): functional implications. Glycobiology, 13(4), 245-254. Leymarie, N., & Zaia, J. (2012). Effective use of mass spectrometry for glycan and glycopeptide structural analysis. Anal Chem, 84(7), 3040-3048. Link, A., Vogt, T. K., Favre, S., Britschgi, M. R., Acha-Orbea, H., Hinz, B., et al. (2007). Fibroblastic reticular cells in lymph nodes regulate the homeostasis of naive T cells. Nat Immunol, 8(11), 1255-1265. Loboda, A. V., Krutchinsky, A. N., Bromirski, M., Ens, W., & Standing, K. G. (2000). A tandem quadrupole/time-of-flight mass spectrometer with a matrix-assisted laser desorption/ionization source: design and performance. Rapid Commun Mass Spectrom, 14(12), 1047-1057. Locatelli, F., Maccario, R., & Frassoni, F. (2007). Mesenchymal stromal cells, from indifferent spectators to principal actors. Are we going to witness a revolution in the scenario of allograft and immune-mediated disorders? Haematologica, 92(7), 872-877. Lu, L. L., Liu, Y. J., Yang, S. G., Zhao, Q. J., Wang, X., Gong, W., et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica, 91(8), 1017-1026. Luther, S. A., Tang, H. L., Hyman, P. L., Farr, A. G., & Cyster, J. G. (2000). Coexpression of the chemokines ELC and SLC by T zone stromal cells and deletion of the ELC gene in the plt/plt mouse. Proc Natl Acad Sci U S A, 97(23), 12694-12699. Malhotra, D., Fletcher, A. L., Astarita, J., Lukacs-Kornek, V., Tayalia, P., Gonzalez, S. F., et al. (2012). Transcriptional profiling of stroma from inflamed and resting lymph nodes defines immunological hallmarks. Nat Immunol, 13(5), 499-510. Malhotra, D., Fletcher, A. L., & Turley, S. J. (2013). Stromal and hematopoietic cells in secondary lymphoid organs: partners in immunity. Immunol Rev, 251(1), 160-176. Merzaban, J. S., Burdick, M. M., Gadhoum, S. Z., Dagia, N. M., Chu, J. T., Fuhlbrigge, R. C., et al. (2011). Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells. Blood, 118(7), 1774-1783. Merzaban, J. S., Imitola, J., Starossom, S. C., Zhu, B., Wang, Y., Lee, J., et al. (2015). Cell surface glycan engineering of neural stem cells augments neurotropism and improves recovery in a murine model of multiple sclerosis. Glycobiology, 25(12), 1392-1409. Michalski, A., Damoc, E., Lange, O., Denisov, E., Nolting, D., Muller, M., et al. (2012). Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol Cell Proteomics, 11(3), O111.013698. Mohal, J. S., Tailor, H. D., & Khan, W. S. (2012). Sources of adult mesenchymal stem cells and their applicability for musculoskeletal applications. Curr Stem Cell Res Ther, 7(2), 103-109. Morelle, W., Faid, V., & Michalski, J. C. (2004). Structural analysis of permethylated oligosaccharides using electrospray ionization quadrupole time-of-flight tandem mass spectrometry and deutero-reduction. Rapid Commun Mass Spectrom, 18(20), 2451-2464. Morelle, W., & Michalski, J. C. (2004). Sequencing of oligosaccharides derivatized with benzylamine using electrospray ionization-quadrupole time of flight-tandem mass spectrometry. Electrophoresis, 25(14), 2144-2155. Moremen, K. W., Tiemeyer, M., & Nairn, A. V. (2012). Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol, 13(7), 448-462. Muller, G., & Lipp, M. (2003). Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr Opin Immunol, 15(2), 217-224. Muramatsu, T., & Muramatsu, H. (2004). Carbohydrate antigens expressed on stem cells and early embryonic cells. Glycoconj J, 21(1-2), 41-45. Nauta, A. J., & Fibbe, W. E. (2007). Immunomodulatory properties of mesenchymal stromal cells. Blood, 110(10), 3499-3506. Neuman, M. G., French, S. W., French, B. A., Seitz, H. K., Cohen, L. B., Mueller, S., et al. (2014). Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol, 97(3), 492-510. North, S. J., Jang-Lee, J., Harrison, R., Canis, K., Ismail, M. N., Trollope, A., et al. (2010). Mass spectrometric analysis of mutant mice. Methods Enzymol, 478, 27-77. Nystedt, J., Anderson, H., Tikkanen, J., Pietila, M., Hirvonen, T., Takalo, R., et al. (2013). Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells. Stem Cells, 31(2), 317-326. Onder, L., Narang, P., Scandella, E., Chai, Q., Iolyeva, M., Hoorweg, K., et al. (2012). IL-7-producing stromal cells are critical for lymph node remodeling. Blood, 120(24), 4675-4683. Pachon-Pena, G., Donnelly, C., Ruiz-Canada, C., Katz, A., Fernandez-Veledo, S., Vendrell, J., et al. (2016). A Glycovariant of Human CD44 is Characteristically Expressed on Human Mesenchymal Stem Cells. Stem Cells. Pan, S., Wang, Y., Quinn, J. F., Peskind, E. R., Waichunas, D., Wimberger, J. T., et al. (2006). Identification of glycoproteins in human cerebrospinal fluid with a complementary proteomic approach. J Proteome Res, 5(10), 2769-2779. Peterman, S. M., & Mulholland, J. J. (2006). A novel approach for identification and characterization of glycoproteins using a hybrid linear ion trap/FT-ICR mass spectrometer. J Am Soc Mass Spectrom, 17(2), 168-179. Pinho, S. S., & Reis, C. A. (2015). Glycosylation in cancer: mechanisms and clinical implications. Nat Rev Cancer, 15(9), 540-555. Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284(5411), 143-147. Prockop, D. J. (1997). Marrow stromal cells as stem cells for nonhematopoietic tissues. Science, 276(5309), 71-74. Randall, T. D., Carragher, D. M., & Rangel-Moreno, J. (2008). Development of secondary lymphoid organs. Annu Rev Immunol, 26, 627-650. Rapoport, E. M., Pazynina, G. V., Sablina, M. A., Crocker, P. R., & Bovin, N. V. (2006). Probing sialic acid binding Ig-like lectins (siglecs) with sulfated oligosaccharides. Biochemistry (Mosc), 71(5), 496-504. Reinhold, V. N., Reinhold, B. B., & Chan, S. (1996). Carbohydrate sequence analysis by electrospray ionization-mass spectrometry. Methods Enzymol, 271, 377-402. Ritamo, I., Rabina, J., Natunen, S., & Valmu, L. (2013). Nanoscale reversed-phase liquid chromatography-mass spectrometry of permethylated N-glycans. Anal Bioanal Chem, 405(8), 2469-2480. Robbe, C., Capon, C., Maes, E., Rousset, M., Zweibaum, A., Zanetta, J. P., et al. (2003). Evidence of regio-specific glycosylation in human intestinal mucins: presence of an acidic gradient along the intestinal tract. J Biol Chem, 278(47), 46337-46348. Robbe, C., Capon, C., Coddeville, B., & Michalski, J. C. (2004). Diagnostic ions for the rapid analysis by nano-electrospray ionization quadrupole time-of-flight mass spectrometry of O-glycans from human mucins. Rapid Commun Mass Spectrom, 18(4), 412-420. Romanov, Y. A., Svintsitskaya, V. A., & Smirnov, V. N. (2003). Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells, 21(1), 105-110. Rosen, S. D. (2004). Ligands for L-selectin: homing, inflammation, and beyond. Annu Rev Immunol, 22, 129-156. Ruster, B., Gottig, S., Ludwig, R. J., Bistrian, R., Muller, S., Seifried, E., et al. (2006). Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells. Blood, 108(12), 3938-3944. Sackstein, R., Merzaban, J. S., Cain, D. W., Dagia, N. M., Spencer, J. A., Lin, C. P., et al. (2008). Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nat Med, 14(2), 181-187. Sagi, D., Peter-Katalinic, J., Conradt, H. S., & Nimtz, M. (2002). Sequencing of tri- and tetraantennary N-glycans containing sialic acid by negative mode ESI QTOF tandem MS. J Am Soc Mass Spectrom, 13(9), 1138-1148. Salem, H. K., & Thiemermann, C. (2010). Mesenchymal stromal cells: current understanding and clinical status. Stem Cells, 28(3), 585-596. Schopperle, W. M., & DeWolf, W. C. (2007). The TRA-1-60 and TRA-1-81 human pluripotent stem cell markers are expressed on podocalyxin in embryonal carcinoma. Stem Cells, 25(3), 723-730. Seymour, J. L., Costello, C. E., & Zaia, J. (2006). The influence of sialylation on glycan negative ion dissociation and energetics. J Am Soc Mass Spectrom, 17(6), 844-854. Stowell, S. R., Ju, T., & Cummings, R. D. (2015). Protein glycosylation in cancer. Annu Rev Pathol, 10, 473-510. Suzuki-Inoue, K. (2011). Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation. J Biochem, 150(2), 127-132. Takegawa, Y., Ito, S., Yoshioka, S., Deguchi, K., Nakagawa, H., Monde, K., et al. (2004). Structural assignment of isomeric 2-aminopyridine-derivatized oligosaccharides using MSn spectral matching. Rapid Commun Mass Spectrom, 18(4), 385-391. Tateno, H., Crocker, P. R., & Paulson, J. C. (2005). Mouse Siglec-F and human Siglec-8 are functionally convergent paralogs that are selectively expressed on eosinophils and recognize 6'-sulfo-sialyl Lewis X as a preferred glycan ligand. Glycobiology, 15(11), 1125-1135. Torii, T., Fukuta, M., & Habuchi, O. (2000). Sulfation of sialyl N-acetyllactosamine oligosaccharides and fetuin oligosaccharides by keratan sulfate Gal-6-sulfotransferase. Glycobiology, 10(2), 203-211. Torres, C. R., & Hart, G. W. (1984). Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem, 259(5), 3308-3317. Uchimura, K., Gauguet, J. M., Singer, M. S., Tsay, D., Kannagi, R., Muramatsu, T., et al. (2005). A major class of L-selectin ligands is eliminated in mice deficient in two sulfotransferases expressed in high endothelial venules. Nat Immunol, 6(11), 1105-1113. Uezumi, A., Ojima, K., Fukada, S., Ikemoto, M., Masuda, S., Miyagoe-Suzuki, Y., et al. (2006). Functional heterogeneity of side population cells in skeletal muscle. Biochem Biophys Res Commun, 341(3), 864-873. van de Pavert, S. A., & Mebius, R. E. (2010). New insights into the development of lymphoid tissues. Nat Rev Immunol, 10(9), 664-674. Varki, A. (1993). Biological roles of oligosaccharides: all of the theories are correct. Glycobiology, 3(2), 97-130. Varki, A. (2008). Sialic acids in human health and disease. Trends Mol Med, 14(8), 351-360. Varki, A., Cummings, R. D., Aebi, M., Packer, N. H., Seeberger, P. H., Esko, J. D., et al. (2015). Symbol Nomenclature for Graphical Representations of Glycans. Glycobiology, 25(12), 1323-1324. Venable, J. D., Dong, M. Q., Wohlschlegel, J., Dillin, A., & Yates, J. R. (2004). Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectra. Nat Methods, 1(1), 39-45. Viseux, N., de Hoffmann, E., & Domon, B. (1997). Structural analysis of permethylated oligosaccharides by electrospray tandem mass spectromet | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/21015 | - |
dc.description.abstract | 人類間質幹細胞屬於一種具有多功能性分化能力的成體幹細胞,在人體中主要存在於骨髓、脂肪、臍帶血或胎盤等部位,同時也具有能夠在體外被培養及分化成數種細胞的能力,包含硬骨、軟骨細胞、脂肪、肌肉及神經細胞等,因此被廣泛地應用在再生醫學與組織工程等方面的研究上。目前已有不少臨床治療的試驗研究嘗試使用間質幹細胞重建與治療疾病但由於間質幹細胞移轉到受傷部位的效果不彰,使得治療效果十分有限。有些研究認為,細胞膜表面的醣化修飾,或許是影響間質幹細胞移轉效率的因素之一,然而我們對於間質幹細胞以及由其分化的數種細胞表面醣化修飾的了解,仍然有限。
另外位於周邊淋巴組織,其特化的高內皮靜脈系統外圍,分布一種稱為纖維網狀的細胞,具有支撐結構的物理性功能,同時也分泌數種生物因子,包含介白素-7 (IL-7)與紅血球生成素等,因此纖維網狀細胞在周邊淋巴系統中也扮演了舉足輕重的角色,但截至目前為止,由於其不易被取得以及在體外難以被分化的性質,使得我們對於其細胞表面的醣質化結構仍然一無所知。 目前我們已知纖維網狀細胞可以於體外培養的情況下,由人類間質幹細胞所分化而得,因此此論文的主要目的是希望應用我們先前所建立的硫酸化醣質體分析系統,搭配高敏感度、高精確性的質譜儀 (Mass spectrometry, MS),來分析人類骨髓間質幹細胞、以及其所分化成的纖維網狀細胞表面的醣質化修飾結構,包含N與O型醣鏈、以及其硫酸化醣質修飾結構;另一方面,在此論文當中我們會一併研究人類間質幹細胞分化成的硬骨細胞及脂肪細胞的醣質化結構,作為一種比較及依據,尤其將重點放在尚未被研究過的硫酸化醣質體結構上。 總體而言,人類間質幹細胞在經由不同的特定生物激素刺激下,在分化14天之後可分別形成硬骨細胞以及脂肪細胞,另外分化成gp38+ 的似纖維網狀幹細胞,則需要7天的時間。接著我們取下細胞表面蛋白質上的醣類,利用質譜儀分析其結構、進行比較。我們發現基本上,這4種類型細胞的醣質化修飾結構很相似,其N型醣鏈主要由高甘露醣鏈組成,而complex type N型醣鏈則大多在其還原端的乙醯基葡萄糖胺(GlcNAc)上帶有一個岩藻醣 (fucose),且具有1-5個乙醯基乳糖胺分支;在其非還原末端上,可分別帶有1-4個的唾液酸,少量的幾種N型醣鏈可同時擁有2個岩藻醣,形成主要帶有H type 2與LeX的末端醣質修飾結構。另外,大多數這些N型醣鏈的非還原端被發現可同時攜帶1-2個硫酸基,且主要的末端醣質結構是帶有1個硫酸基的乙醯基乳糖胺 (sulfated LacNAc)。在4組細胞的比較當中,gp38+ 的似纖維網狀幹細胞表現較多的雙岩藻醣化及唾液酸化,然而在其他方面,這4組細胞並未存在著太顯著的差異。O型醣鏈的部分則主要是由Core 1和Core 2及其延伸的結構所組成,主要帶有1-2個唾液酸,並且少量帶有1個唾液酸的Core 2結構亦可被單岩藻醣化,形成帶有H type 2、LeX,以及sLeX的末端醣質修飾結構。這些主要的O型醣鏈亦可攜帶1個硫酸基,在其非還原端末端形成帶有單個硫酸基的乙醯基乳糖胺、岩藻醣化乙醯基乳糖胺的末端結構,且硫酸基的位置主要在乙醯基葡萄糖胺的6號碳位置上,同時我們也發現有末端硫酸化唾液酸的存在。 綜言之,此論文透過分析人類間質幹細胞以及其所分化的似纖維間質幹細胞、硬骨細胞以及脂肪細胞的醣質化和硫酸醣質化修飾結構,希望藉此在結構工程學的研究方面,能夠提供一個整體的醣質體圖譜概念,使其能夠改善人類間質幹細胞在再生醫學臨床應用上的效能。 | zh_TW |
dc.description.abstract | Human mesenchymal stem cells (MSCs) are adult multipotent progenitor cells that have therapeutic potential for regenerative medicine and are easy to induce into several differentiated types of cells, including adipocytes, chondrocytes, osteoblasts and fibroblast reticular cells, providing great potential in regenerative therapy. To date, there is little knowledge on the chemical properties of glycosylated surface markers characterizing MSCs and their various differentiated stages, particularly those of sulfated N- and O-glycans. Besides, fibroblast reticular cells (FRC) play vital roles in the high endothelial venules (HEV) system in peripheral lymph organs, in which they physically support HEV scaffold and secret survival essential cytokines for lymphoid cells, including interleukin-7 (IL-7). However, the glycomics of FRC had never been investigated.
In this study, we aimed to identify several development stage-specific glycans by a mass spectrometry (MS)-based glycomic mapping of the N- and O-glycans of undifferentiated and 14 days adipogenically/osteogenically differentiated human MSCs, as well as gp38+ derived from human MSCs after 7 days of differentiation. We first obtained an overall MS profile of permethylated non-sulfated and sulfated glycans by MALDI-MS analysis in positive and negative ion modes, respectively, followed by advanced nanoLC-MS2/MS3 analysis to identify the glycotopes. We found that the complex type N-glycans were mostly core-fucosylated when carrying a single fucose but Lewis X and H type 2 could be identified. Almost all of the N-glycans including those with mono- to tetra-sialylated and those carrying poly-N-acetyllactosamine structures were found to have mono- and disulfated counterparts carrying sulfates on the GlcNAc or Gal of the LacNAc unit, and primarily the sulfate located at 6 arm of GlcNAc. Moreover, gp38+ cells expressed more di-fucosylated and sialylation level of non-sulfated N-glycans and more fucosylation at mono-sulfated N-glycans compared with other 3 types of cells. The major O-glycans of MSCs and their differentiated progenies were mostly based on mono- or di-sialylated extended core 1 and 2 structures, some of which additionally fucosylated and most could also be mono-sulfated. The major glycotopes of non-sulfated O-glycans were H type 2 and LeX, as well as sLeX, and the predominant sulfoglycotopes was sulfated LacNAc, while lower level of sulfated fucosyl LacNAc could also be observed. The location of sulfate was primarily on the 6 position of GlcNAc (GlcNAc6S), but minor Gal6S, Gal3S and sulfated sialic acid also existed. Upon induced differentiation to different progenies, gp38+ cells was found to have more mono- and di-sialylation non-sulfated O-glycans, whereas adipocyte showed less of those but more non-sulfated core 1 and core 2 structures. Besides, gp38+ cells seemed to express less mono-sialylated mono-sulfated O-glycans compared with the others. | en |
dc.description.provenance | Made available in DSpace on 2021-06-08T03:15:43Z (GMT). No. of bitstreams: 1 ntu-106-D00b46018-1.pdf: 17585635 bytes, checksum: 4ef77281aab9263fe2e07cb8a8edcd13 (MD5) Previous issue date: 2017 | en |
dc.description.tableofcontents | Table of contents
Chapter 1. Introduction................................................................................................. 1 1.1 Mammalian glycosylation and the related functions………...…………….……. 1 1.2 Significance of sulfated N- and O-glycans in biological system………………...6 1.2.1 Gal/GalNAc/GlcNAc-6-O sulfotransferases…………………………………......6 1.2.2 Biological role of sulfated glycans mediated lymphocyte homing……………...8 1.2.3 Other biological functions of sulfated glycans…….………...................….………8 1.3 Biological significance of mesenchymal stem cell……………………………….10 1.3.1 Glycomics of MSC……………………………………………………………....13 1.3.2 Fibroblastic reticular cells (FRC)……………………………………………......15 1.4 Common approaches for glycosylation analysis and glycomics…..............……16 1.5 Mass spectrometry-based glycomics……………………………………………19 1.5.1 MS and MS/MS analysis of permethylated glycans…………………...…………21 1.5.2 High energy CID-MS/MS of permethylated glycans…………………………..24 1.5.3 HCD on Orbitrap and additional MS/MS features of permethylated sulfated glycans………………………………………………………………………………….26 1.5.4 Current mass spectrometry-based technique for glycomics…..………………..32 1.6 Specific aims……………………………………………..…………...……………35 Chapter 2. Material and Methods………………………........................................... 38 2.1 Culture conditions and MSC differentiation and staining………………...….38 2.2 Glycans releasing from cell lysate…………………………...…………………39 2.3 Oligosaccharides Permethylation…………………………...……………………40 2.4 Cleanup of Permethylated glycans…………………………...…………………..40 2.5 MALDI-MS and Targeted LC-MSn analysis…………………………………....41 2.6 LC-MS based analysis…………………………………………………………..41 2.7 Data mining by GlyPick………………………………...………………………44 Chapter 3. Results …………….................................................................................... 47 3.1 MALDI-MS and LC-MS based glycomics of non-sulfated N-glycans for MSC and its differentiated counterparts…………………..………………………….……47 3.1.1 MALDI-MS based glycosylation profiles of permethylated non-sulfated N-glycans of MSC and its differentiated progenies…….….…………………………..47 3.1.2 Global nanoLC-MS2-pd-MS3 analysis of fucosylated glycotopes from permethylated non-sulfated N-glycans of MSC and its differentiated progenies……....49 3.1.3 Detailed MS/MS analyses for structural assignments of permethylated non-sulfated N-glycans…………………………………………………………………51 3.1.4 Summary and Discussion……………………………………………………....54 3.2 MALDI-MS and LC-MS/MS based glycomics of sulfated N-glycans from MSC and its differentiated counterparts…………………………………………………...68 3.2.1 MALDI-MS based glycosylation profiles of permethylated mono-sulfated N-glycans of MSC and its differentiated progenies……………………………………68 3.2.2 NanoLC-MS2-pd-MS3 analysis of the permethylated non-sulfated N-glycans of MSC and its differentiated progenies…………………………………………………..71 3.2.3 MS analysis of di-sulfated N-glycans of MSC and its differentiated progenies..73 3.2.4 Summary and Discussion………………………………………………………...74 3.3 MALDI-MS and LC-MS based glycomics of non-sulfated and sulfated O-glycans from MSC and its differentiated counterparts………………………….86 3.3.1 NanoLC-MS/MS analyses of the permethylated O-glycans of MSC and its differentiated progenies…………………………………………………………...……86 3.3.2 Summary and Discussion………………………………………………………...91 Chapter 4. Discussion…………………………………………….…………….……103 References…………………………………………………...……………………107 List of figures Figure 1-1 Primary types of glycoconjugates……………………………………………3 Figure 1-2 Mammalian glycosylation frameworks……………...………………………6 Figure 1.5-1 Common MS/MS fragment ions generated by (A) low energy CID in Q/TOF and (B) high energy CID in TOF/TOF…………..……………………………24 Figure 1.5-2 Characteristic low mass HCD fragment ions for determination of location of sulfate on terminal glycotopes……………………………………………………….32 Figure 3.1-1 Positive ion mode MALDI-MS profiles of permethylated non-sulfated N-glycans of MSC and its differentiated progenies……...…………………...………..58 Figure 3.1-2 MALDI-MS profiles of permethylated non-sulfated N-glycans from human MSC and the relative quantitative profiles (n=3) of undifferentiated MSC and MSC differentiated Gp38+ cells, osteocytes and adipocytes in positive ion mode…………..60 Figure 3.1-3 The relative amount of different classes of non-sulfated N-glycans derived from MSC and its progenies………………………………….………………………...62 Figure 3.1-4 Schematic cartoon drawings illustrating how the isomeric fucosylated glycotopes can be distinguished by diagnostic MS3 ions………………………………63 Figure 3.1-5 The relative amount of various fucosylated glycotopes carried on the non-sulfated N-glycans derived from MSC and its progenies………………………....64 Figure 3.1-6. Exemplary HCD MS2 spectra of permethylated non-sulfated, biantennary complex type N-glycans from gp38+ cells carrying sialylated and/or fucosylated glycotopes……………………………………………………………………………....66 Figure 3.2-1 Negative ion mode MALDI-MS profiles of permethylated mono-sulfated N-glycans of MSC and its differentiated progenies……………………………………77 Figure 3.2-2 MALDI-MS profiles of permethylated mono-sulfated N-glycans from human MSC and the relative quantitative profiles (n=3) of undifferentiated MSC and MSC differentiated Gp38+ cells, osteocytes and adipocytes in negative ion mode..….78 Figure 3.2-3 The relative amount of different sialylated and fucosylated mono-sulfated N-glycans derived from MSC and its progenies.do-β-galactosidase……………..……80 Figure 3.2-4 CID MS2/MS3 analysis of the most abundant permethylated mono-sulfated sialylated and fucosylated N-glycans…………………………………………………..81 Figure 3.2-5 Negative ion mode MALDI-MS profiles of permethylated di-sulfated N-glycans of MSC and its differentiated progenies…….……………………………...82 Figure 3.2-6. NanoLC-MS/MS analysis of permethylated di-sulfated N-glycans of MSC in negative ion mode……………………………………………………………………84 Figure 3.3-1 Positive ion mode MALDI-MS profiles of permethylated non-sulfated O-glycans of MSC and its differentiated progenies………………………………...….93 Figure 3.3-2 Negative ion mode MALDI-MS profiles of permethylated mono-sulfated O-glycans of MSC and its differentiated progenies……….………………………..….94 Figure 3.3-3 Relative quantification of the permethylated O-glycans of MSC and its differentiated progenies based on nanoLC-MS/MS analyses……..………………..…..95 Figure 3.3-4 HCD MS2 of select permethylated non-sulfated O-glycans to distinguish isomeric structures……………………………………………………………….…......97 Figure 3.3-5 HCD MS2 of select permethylated non-sulfated and sulfated O-glycans to identify major fucosylated and sulfated glycotopes……………………………………99 Figure 3.3-6 HCD MS2 of permethylated sulfated O-glycans from MSC…….…….101 List of Tables Table 3.1-1 Assigned Non-sulfated N-glycans of MSC…………………………...127 Table 3.1-2 Assigned Non-sulfated N-glycans of gp38+……………………………128 Table 3.1-3 Assigned Non-sulfated N-glycans of Osteocyte……………...………130 Table 3.1-4 Assigned Non-sulfated N-glycans of Adipocyte………………...…….132 Table 3.2-1 Assigned Non-sulfated N-glycans of MSC……………………….…..134 Table 3.2-2 Assigned Non-sulfated N-glycans of gp38+………………….…….…136 Table 3.2-3 Assigned Non-sulfated N-glycans of Osteocyte……………….……..138 Table 3.2-4 Assigned Non-sulfated N-glycans of Adipocyte………………...……140 Abbreviation MALDI: matrix assisted laser desorption/ionization TOF: time-of-flight CID: collision-induced dissociation HCD: high collision energy dissociation DABP: 3, 4-diaminobenzophenone DDA: data dependent acquisition DHB: 2, 5-dihydroxybenzoic acid EI: electron impact ESI: electrospray ionization FAB: fast-atom-bombardment Fuc: fucose Gal: Galactose Glc: Glucose GlcNAc: N-acetylglucosamine GalNAc: N-acetylgalactosamine GC: gas chromatography Man: mannose NeuAc: N-Acetylneuraminic Acid Hex: Hexose HexNAc: N-acetylhexosamine HPLC: high-performance liquid chromatography IT: ion trap LacNAc: N-acetyllactosmaine LC: liquid chromatography LPS: lipopolysaccharides LTQ: linear ion trap MS: mass spectrometry PA: 2-aminopyridine Pd-MS3: product dependent MS3 PolyLacNAc: poly-N-acetyllactosamine Q: quadrupole Siglec: sialic acid binding Ig-like protein TFA: trifluoracetic acid XIC: extracted ion chromatogram | |
dc.language.iso | en | |
dc.title | 醣質體之質譜分析應用於人類骨髓間質幹細胞及其分化之細胞 | zh_TW |
dc.title | Mass spectrometry-based glycomics of human bone marrow mesenchymal stem cells and their differentiated progenies | en |
dc.type | Thesis | |
dc.date.schoolyear | 105-1 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 張權發,郭津岑,陳頌方,蕭鶴軒 | |
dc.subject.keyword | 醣質生物學,質譜儀,硫酸化醣質體,甲基化衍生,人類骨髓間質幹細胞,脂肪細胞,骨細胞, | zh_TW |
dc.subject.keyword | Glycobiology,Mass spectrometry (MS),sulfoglycomics,permethylation,human mesenchymal stem cells (MSC),osteocyte,adipocyte, | en |
dc.relation.page | 141 | |
dc.identifier.doi | 10.6342/NTU201700317 | |
dc.rights.note | 未授權 | |
dc.date.accepted | 2017-02-06 | |
dc.contributor.author-college | 生命科學院 | zh_TW |
dc.contributor.author-dept | 生化科學研究所 | zh_TW |
顯示於系所單位: | 生化科學研究所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-106-1.pdf 目前未授權公開取用 | 17.17 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。